[Duphalac (lactulose) in the treatment of chronic constipation in children].
The aim of this study was to estimate the effectiveness of DUPHALAC preparation, produced by Solvay-Pharma, in treatment of functional chronic constipation. 112 children, aged 10 months-15.5 years were examined. DUPHALAC appeared to be very effective, were examined. Only two patients did not accept its taste. Rapidly (approximately after 2.5 weeks) improvement was achieved such as of restoration normal peristalsis and of previously disturbed defecation rhythm, softening of a stool, regression of pain and/or dyspeptic ailments, encopresis and improvement of appetite. In no case undesirable side effects were observed.
Romańczuk
W
W
Oddział Dzieciecy Szpitala Wojewódzkiego Nr 2, Rzeszowie.
Korczowski
R
R
D000293:Adolescent; D002400:Cathartics / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003248:Constipation / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007792:Lactulose / Q000627:therapeutic use*; D008297:Male; D010349:Patient Compliance; D016896:Treatment Outcome
D002400:Cathartics; D007792:Lactulose
Duphalac (laktuloza) w leczeniu przewlekłych zaparć stolca u dzieci.